Deadline to submit feedback is 15 November 2026 The World Anti-Doping Agency is pleased to invite stakeholders to participate ...

The World Anti-Doping Agency (WADA) invites stakeholders to participate in a consultation process regarding a proposed ...

The World Anti-Doping Agency’s (WADA’s) Athlete Engagement and Independent Observer (IO) teams, are in Nagoya, Japan for the ...

The World Anti-Doping Agency (WADA) invites stakeholders to participate in a consultation process regarding the following two new Technical Documents (TDs) related to the International Standard for ...

The current version of the International Standard for Code Compliance by Signatories (ISCCS) went into force on 1 April 2024. The World Anti-Doping Code (Code) makes WADA responsible for monitoring ...

The current version of the International Standard for Testing and Investigations (ISTI) went into force on 1 January 2023. The ISTI, which is mandatory for all World Anti-Doping Code (Code) ...

You can access WADA's 2022 Digital Annual Report here. The Annual Reports from 2021 and earlier are available in PDF in the Archives section below.

Athletes may have illnesses or conditions that require them to take medications. If the medication an athlete is required to take to treat an illness or condition happens to fall under the Prohibited ...

One of six priorities under the WADA’s 2025-2029 Strategic Plan is to ‘Grow Impact’. Under this priority, we have committed ‘to developing training programs and qualifications standards for ...

The World Anti-Doping Code (Code) is the core document that harmonizes anti-doping policies, rules and regulations within sport organizations and among public authorities around the world. It works in ...

The anabolic androgenic steroid estra-4,9-diene-3,17-dione (DD) is not explicitly mentioned on the Prohibited List issued by the World Anti-Doping Agency. This is somewhat unexpected considering that ...